Kala Azar in South Asia Current Status and Sustainable Challenges - Noiri, E.; Jha, T.K.; SpringerLink (Online service) (Cham : Springer International Publishing : Imprint: Springer, 2016)
Preface. Part I Introduction into Kala-Azar Pathology and Mechanism of Disease in Kala-Azar -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Characteristics of Patients Visiting Suruya Kanta Kala-Azar Research Center in Mymensingh, Bangladesh; Data from a Patient Registry System -- Epidemiology of Drug-Resistant Kala-Azar in India and Neighboring Countries -- Part II Therapeutic Strategy to Deal with Emergence of Drug Resistance -- A Therapeutic Strategy for Treating Visceral Leishmaniasis in Regions with Drug Resistance -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Combination Therapy for Leishmaniasis -- Vaccine Development for Leishmaniasis -- Siccanin is a novel selective inhibitor of trypanosomatid complex II (succinate-ubiquinone reductase) and a potent broad-spectrum anti-trypanosomatid drug candidate -- Challenges in the Diagnosis of Visceral Leishmaniasis on the Indian Subcontinent -- Part III Diagnostic Strategy Enhancing Kala-Azar Elimination Program -- Changes of Leishmania antigens in kala-azar patients' urine after treatment -- Potentiality of Urinary L-FABP Tests to Kala-azar Disease Management -- Antibody Capture Direct Agglutination Test (abcDAT) for Diagnosis of Visceral Leishmaniasis with Urine -- Loop-mediated Isothermal Amplification (LAMP): Molecular Diagnosis for the Field Survey of Visceral Leishmaniasis -- Applicability of Multiplex Real-Time PCR to Visceral Leishmaniasis -- Immunoglobulins in the Pathophysiology of Visceral Leishmaniasis -- Part V Knowledge and Practice for Vector Control in Kala-Azar -- Geographical Distribution and Ecological Aspect of Sand Fly Species in Bangladesh -- The efficacy of long lasting insecticidal nets for leishmaniasis in Asia -- Environmental change and kala-azar with particular reference to Bangladesh -- Part VI. New Challenges in the Kala-azar Elimination Programme -- Drug Safety Monitoring for Liposomal Amphotericin B -- Resolution Mapping of Kala-azar Hot Spots Using GPS Logger and Urinary Antibody Measurements -- Geography and Reality of Kala-azar Endemic in Bangladesh, Analysis Using GIS and Urine-based Mass Screening -- Animal Models of Visceral Leishmaniasis and Applicability to Disease Control -- Pharmacovigilance on Therapeutic Protocols for Visceral Leishmaniasis. Index.
Keywords: Parasitology; Drug resistance; Veterinary medicine; Laboratory medicine; Nephrology; Parasitology; Drug Resistance; Veterinary Medicine/Veterinary Science; Laboratory Medicine; Nephrology